We identified five genes (ITGA5, MMP9, PTPRN, PTX3, and STX1A) that could significantly affect the OS rate of patients, and the difference between the tumor group and the normal group was statistically significant (Figures 5A–E). This evidence concerns the gene PTX3 and neoplasm.